This inventor holds 3 USPTO granted patents and 3 EPO patents. Top assignee: Consiglio Nazionale Delle Ricerche. Active years: 2012-2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012-2019
Title: Nicoletta Corbi: Innovator in Muscular Dystrophy Treatment
Introduction
Nicoletta Corbi is a prominent inventor based in Rome, Italy. She has made significant contributions to the field of medical research, particularly in the treatment of muscular dystrophy. With a total of 3 patents to her name, her work focuses on innovative methods to address muscle diseases.
Latest Patents
Nicoletta's latest patents include groundbreaking inventions aimed at treating muscular dystrophy. One of her notable patents features modified human transcription factors capable of increasing utrophin expression. This invention also includes recombinant adeno-associated vectors for the delivery of these modified transcription factors, along with methods for treating muscle diseases, including Duchenne's muscular dystrophy. Another patent she holds involves recombinant adeno-associated vectors designed for delivering genes to both skeletal and cardiac muscle, providing methods for treating muscle defects, particularly in cases of Duchenne's muscular dystrophy.
Career Highlights
Nicoletta Corbi is affiliated with the Consiglio Nazionale delle Ricerche, where she continues her research and development efforts. Her work has garnered attention for its potential to improve the quality of life for individuals affected by muscular dystrophy.
Collaborations
Some of her notable coworkers include Claudio Passananti and Maria Grazia Di Certo, who contribute to her research endeavors.
Conclusion
Nicoletta Corbi stands out as an influential inventor in the realm of muscular dystrophy treatment. Her innovative patents and dedication to research highlight her commitment to advancing medical science and improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
